Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 3, 2009, Pages 289-294

  Nace, Heather L ^a,b   Horn, David ^b   Neofytos, Dionissios ^b,c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Candidemia; Fungemia; Multiple species

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; CORTICOSTEROID; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDEMIA; CLINICAL ARTICLE; COMORBIDITY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FEMALE; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FEMALE; FUNGEMIA; HOSPITALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67349152076     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.03.010     Document Type: Article

References (24)

1. Abi-Said D., Anaissie E., Uzun O., Raad I., Pinzcowski H., and Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24 (1997) 1122-1128
2. Anaissie E.J., Rex J.H., Uzun O., and Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am. J. Med. 104 (1998) 238-245
3. Boktour M.R., Kontoyiannis D.P., Hanna H.A., Hachem R.Y., Girgawy E., Bodey G.P., and Raad I.I. Multiple-species candidemia in patients with cancer. Cancer 101 (2004) 1860-1865
4. Chang A., Neofytos D., and Horn D. Candidemia in the 21st century. Future Microbiol. 3 (2008) 463-472
5. Chen S., Slavin M., Nguyen Q., Marriott D., Playford E.G., Ellis D., and Sorrell T. Active surveillance for candidemia, Australia. Emerg. Infect. Dis. 12 (2006) 1508-1516
6. Chow J.K., Golan Y., Ruthazer R., Karchmer A.W., Carmeli Y., Lichtenberg D., Chawla V., Young J., and Hadley S. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin. Infect. Dis. 46 (2008) 1206-1213
7. Edmond M.B., Wallace S.E., McClish D.K., Pfaller M.A., Jones R.N., and Wenzel R.P. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29 (1999) 239-244
8. Guerra-Romero L., Telenti A., Thompson R.L., and Roberts G.D. Polymicrobial fungemia: microbiology, clinical features, and significance. Rev. Infect. Dis. 11 (1989) 208-212
9. Horn D.L., Fishman J.A., Steinbach W.J., Anaissie E.J., Marr K.A., Olyaei A.J., Pfaller M.A., Weiss M.A., Webster K.M., and Neofytos D. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. Diagn. Microbiol. Infect. Dis. 59 (2007) 407-414
10. Horn D.L., and Neofytos D. Contemporary patterns in the use of antifungal agents in the treatment of invasive fungal infections: perspectives from registries and databases. Curr. Fungal Infect. Rep. 1 (2007) 72-78
11. Jensen J., Muñoz P., Guinea J., Rodríguez-Créixems M., Peláez T., and Bouza E. Mixed fungemia: incidence, risk factors, and mortality in a general hospital. Clin. Infect. Dis. 44 (2007) e109-e114
12. Klotz S.A., Chasin B.S., Powell B., Gaur N.K., and Lipke P.N. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn. Microbiol. Infect. Dis. 59 (2007) 401-406
13. Morgan J., Meltzer M.I., Plikaytis B.D., Sofair A.N., Huie-White S., Wilcox S., Harrison L.H., Seaberg E.C., Hajjeh R.A., and Teutsch S.M. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect. Control Hosp. Epidemiol. 26 (2005) 540-547
14. Neofytos D, Katz-Slenker A, Horn D (2007) Candidemia incidence, Candida spp. epidemiology and antifungal use in a tertiary care center. Poster Session, Abstract # 167, IDSA, San Diego CA.
15. Nguyen M.H., Peacock Jr. J.E., Morris A.J., Tanner D.C., Nguyen M.L., Snydman D.R., Wagener M.M., Rinaldi M.G., and Yu V.L. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100 (1996) 617-623
16. Nieto-Rodriguez J.A., Kusne S., Manez R., Irish W., Linden P., Magnone M., Wing E.J., Fung J.J., and Starzl T.E. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann. Surg. 223 (1996) 70-76
17. Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W.E., Walsh T.J., and Edwards J.E. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38 (2004) 161-189
18. Pfaller M.A., Jones R.N., Messer S.A., Edmond M.B., Wenzel R.P., and SCOPE Participant Group. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis. 30 (1998) 121-129
19. Pfaller M.A., and Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20 (2007) 133-163
20. Poikonen E., Lyytikainen O., Anttila V.J., and Ruutu P. Candidemia in Finland, 1995-1999. Emerg. Infect. Dis. 9 (2003) 985-990
21. Pulimood S., Ganesan L., Alangaden G., and Chandrasekar P. Polymicrobial candidemia. Diagn. Microbiol. Infect. Dis. 44 (2002) 353-357
22. Trick W.E., Fridkin S.K., Edwards J.R., Hajjeh R.A., and Gaynes R.P. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis. 35 (2002) 627-630
23. Weinstein M.P., Reller L.B., and Murphy J.R. Clinical importance of polymicrobial bacteremia. Diagn. Microbiol. Infect. Dis. 5 (1986) 185-196
24. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39 (2004) 309-317